Priming with an HEV Th epitope can improve the humoral immunogenicity of its native protein

Shengwu Gongcheng Xuebao/Chinese Journal of Biotechnology

Volumn 23, Issue 2, 2007, Pages 310-314

  Lin, Chun Xin ^a   Wu, Ting ^a   Wu, Xiao Lu ^a   Xie, Ming Hui ^a   Cheng, Tong ^a   Li, Shao Wei ^a   Zhang, Jun ^a   Xia, Ning Shao ^a  

^a XIAMEN UNIVERSITY   (China)

Author keywords

Hepatitis E virus; Immunogenicity; T epitope; Th cell

Indexed keywords

HEPATITIS E VIRUS; MUS;

EPITOPE; INTERFERON; VIRUS ANTIBODY; VIRUS VACCINE;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BLOOD; CELL PROLIFERATION; CELL SURVIVAL; CYTOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HEPATITIS E VIRUS; IMMUNIZATION; IMMUNOLOGY; METABOLISM; METHODOLOGY; MOUSE; SPLEEN; T LYMPHOCYTE;

ANIMALS; ANTIBODIES, VIRAL; CELL PROLIFERATION; CELL SURVIVAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; FEMALE; FLOW CYTOMETRY; HEPATITIS E VIRUS; IMMUNIZATION; IMMUNIZATION, SECONDARY; INTERFERONS; MICE; MICE, INBRED BALB C; SPLEEN; T-LYMPHOCYTES; VIRAL VACCINES;

EID: 77951912399     PISSN: 10003061     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Li SW, Zhang J, Li YM, et al. A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates. Vaccine, 2005, 23(22): 2893-2901.
2. Li SW, Zhang J, He ZQ, et al. Mutational analysis of essential interactions involved in the assembly of hepatitis E virus capsid. J Biol Chem, 2005, 280(5): 3400-3406.
3. Wu T, Ou SH, Cheng T, et al. Immune response induced by recombinant particulate hepatitis E virus vaccine in mice. Chinese Journal of Virology, 2005, 21(6): 422-427.
4. Zhang JZ, Ng MH, Xia NS, et al. Conformational antigenic determinants generated by interactions between a bacterially expressed recombinant peptide of the hepatitis E virus structural protein. J Med Virol, 2001, 64(2): 125-132.
5. Li SW, Zhang JZ, Zhuang H, et al. A bacterially expressed peptide prevents experimental infection of primates by the hepatitis E virus. Vaccine, 2001, 19(27): 3726-3732.
6. Zhang J, Gu Y, Ge SX, et al. Analysis of hepatitis E virus neutralization sites using monoclonal antibodies directed against a virus capsid protein. Vaccine, 2005, 23(22): 2881-2892.
7. Ge SX, Zhang J, Huang GY, et al. Protective efficacy of a particulate recombinant (E. coli) hepatitis E vaccine on Rhesus Monkey. Acta Microbiologica Sinica, 2003, 43(1): 35-42.
8. d restricted Th epitope in hepatitis E virus particulate vaccine HEV 239. Chinese Journal of Virology, 2006, 22(3): 176-179.
9. Garside P, Ingulli E, Merica RR, et al. Visualization of specific B and T lymphocyte interactions in the lymph node. Science, 1998, 281(5373): 96-99.
10. Farber DL. Remembrance of antigens past: new insights into memory T cells. Scand J Immunol, 2003, 58(2): 145-154.
11. Ahmadzadeh M, Farber DL. Functional plasticity of an antigen-specific memory CD4 T cell population. Proc Natl Acad Sci USA, 2002, 99(18): 11802-11807.
12. Kirnbauer R, Booy F, Cheng N, et al. Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proc Natl Acad Sci USA, 1992, 89(24): 12180-12184.
13. Lopez de Turiso JA, Cortes E, Martinez C, et al. Recombinant vaccine for canine parvovirus in dogs. J Virol, 1992, 66(5): 2748-2753.
14. Martinez C, Dalsgaard K, Lopez de Turiso JA, et al. Production of porcine parvovirus empty capsids with high immunogenic activity. Vaccine, 1992, 10(10): 684-690.
15. Marin MS, Martin Alonso JM, Perez Ordoyo Garcia LI, et al. Immunogenic properties of rabbit haemorrhagic disease virus structural protein VP60 expressed by a recombinant baculovirus: an efficient vaccine. Virus Res, 1995, 39(2-3): 119-128.